Showing all 7 resultsSorted by popularity
BPC 157 + TB-500 is a integrated tissue repair stack combining the angiogenic pentadecapeptide BPC 157 with the actin-binding regenerative peptide TB-500. Together they accelerate fibroblast migration, angiogenesis, and wound contraction for full-scale connective tissue healing.
Retatrutide + Cagrilintide blend is a quadruple-receptor agonist formulation combining a GLP-1/GIP/GCGR triple agonist with a long-acting amylin analog. It simultaneously drives incretin-mediated glycemic control, glucagon-stimulated energy expenditure, and hindbrain appetite suppression for extreme metabolic synergy.
Dual GLP-1/GIP receptor agonist for weight management and metabolic research. Study incretin signaling and glucose regulation.
Semax + Selank is a cooperative nootropic blend combining an ACTH(4-10)-derived heptapeptide with an anxiolytic tuftsin analog. Semax upregulates BDNF and NGF for cognitive enhancement, while Selank modulates GABAergic pathways for stress relief. Together they offer broad-spectrum neuroprotection.
Tesamorelin + Ipamorelin is a complementary GHRH/GHRP stack that combines a stabilized 44-amino acid GHRH analog with a selective ghrelin receptor agonist. Tesamorelin drives sustained visceral fat lipolysis while Ipamorelin amplifies GH pulsatility without ACTH or prolactin side effects.
Long-acting GLP-1 receptor agonist for appetite regulation and metabolic research. Investigate weight management pathways.
Cagri-Sema is a integrated dual-peptide blend of Cagrilintide and Semaglutide that simultaneously activates amylin/calcitonin and GLP-1 receptors for full-scale appetite suppression and glycemic control. This combination overcomes the receptor saturation plateau of GLP-1 monotherapy.
End of content
End of content
No products in the cart.
